Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study

Introduction In patients with psoriatic arthritis (PsA) an increased cardiovascular (CV) risk has been observed. Recently, a EULAR taskforce suggested to use a multiplication by the factor of 1.5 of CV risk algorithms in patients with inflammatory arthritis. This study aims to evaluate the performance of five original and adapted according to EULAR recommendations CV risk algorithms in PsA: SCORE, CUORE, Framingham Risk Score (FRS), QRISK2, and Reynold’s Risk Score (RRS). Methods Prospectively collected data from two Italian cohorts were used. Discriminatory ability for CV risk prediction was evaluated by the area under the ROC curves. Calibration between predicted and observed events was assessed by Hosmer-Lemeshow (HL) tests. Sensibility and specificity were calculated for low-to-intermediate and intermediate-to-high risk cut-offs. Results One hundred fifty-five patients were enrolled with an observation of 1550 patient/years. Area under the ROC were 0.7679 (95% CI 0.64768 to 0.88812), 0.864 (95% CI 0.79675 to 0.93278), 0.7575 (95% CI 0.65784 to 0.85708), 0.8660 (95% CI 0.79428 to 0.93772), and 0.7183 (95% CI 0.57795 to 0.85862) for SCORE, CUORE, FRS, QRSIK2, and RRS, respectively. HL tests demonstrated poor model fit (p<0.05) for SCORE, CUORE, and RRS. Discriminative ability and calibration were not improved by adaption of the algorithms according to EULAR recommendations. Up to 80% of CV events occurred in patients at “low risk” and up to 93% of CV events in patients at “low-intermediate risk”. Conclusions Adaption of the CV risk algorithms according to EULAR indications did not provide improvement in discriminative ability and calibration in patients with PsA.

[1]  L. Puig Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis , 2017, International journal of molecular sciences.

[2]  M. Chang,et al.  Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis , 2017, The Journal of Rheumatology.

[3]  L. Eder,et al.  Cardiometabolic Disorders in Psoriatic Disease , 2017, Current Rheumatology Reports.

[4]  M. Martínez-Vidal,et al.  Is the SCORE chart underestimating the real cardiovascular (CV) risk of patients with psoriatic arthritis? Prevalence of subclinical CV disease detected by carotid ultrasound. , 2017, Joint, bone, spine : revue du rhumatisme.

[5]  M. Pletcher,et al.  Cardiovascular Risk Assessment. , 2017, The Medical clinics of North America.

[6]  J. Primdahl,et al.  EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update , 2016, Annals of the rheumatic diseases.

[7]  D. Gladman,et al.  Incidence and predictors for cardiovascular events in patients with psoriatic arthritis , 2015, Annals of the rheumatic diseases.

[8]  E. Matteson,et al.  Cardiovascular Risk Profile at the Onset of Psoriatic Arthritis: A Population‐Based Cohort Study , 2015, Arthritis care & research.

[9]  G. Kitas,et al.  Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis , 2014, Annals of the rheumatic diseases.

[10]  M. R. Bongiorno,et al.  Psoriasis and Cardiovascular Risk: Assessment by CUORE Project Risk Score in Italian Patients , 2013, Dermatology research and practice.

[11]  D. Gladman,et al.  The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease , 2013, Annals of the rheumatic diseases.

[12]  T. Therneau,et al.  Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. , 2012, The American journal of cardiology.

[13]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[14]  P. Strazzullo,et al.  Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study , 2012, Clinical Rheumatology.

[15]  L. Punzi,et al.  Atherosclerosis in psoriatic arthritis. , 2011, Autoimmunity reviews.

[16]  N. Paynter,et al.  C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men , 2008, Circulation.

[17]  A. Sheikh,et al.  Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 , 2008, BMJ : British Medical Journal.

[18]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[19]  N. Cook,et al.  Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.

[20]  Dafna Gladman,et al.  Classification criteria for psoriatic arthritis: development of new criteria from a large international study. , 2006, Arthritis and rheumatism.

[21]  D. Gladman,et al.  Psoriatic Arthritis. , 2017, The New England journal of medicine.

[22]  K. Yim,et al.  Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms , 2016, Rheumatology International.